Markets:

Overview

News

Currencies

International

Treasuries

CRISPR Therapeutics AG - Common Shares (NQ:CRSP)

55.15 +1.38 (+2.57%)

Official Closing Price Updated: 4:15 PM EST, Jan 5, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about CRISPR Therapeutics AG - Common Shares

< Previous 1 2

...

5 6 7 8 9 10 11 12 13

...

34 35 Next >

Stock Market Crash Alert: 3 Must-Buy Biotech Stocks When Prices Plunge ↗

May 01, 2024

A slip in the market could give investors a rare opportunity to get some top biotech stocks to buy at a considerable discount.

Via InvestorPlace

Missed Out on Novo Nordisk? 2 Healthcare Stocks With Big Catalysts on the Horizon. ↗

April 24, 2024

Good news could be just around the corner for two drugmakers not named Novo Nordisk.

Via The Motley Fool

Vertex Pharmaceuticals Just Made 2 Big Moves. Is the Stock a Buy? ↗

April 23, 2024

Vertex is broadening its portfolio.

Via The Motley Fool

3 Magnificent Stocks That Could Double or More by 2030 ↗

April 13, 2024

There's no guarantee these stocks will double by 2030, but their growth prospects look great.

Via The Motley Fool

Wall Street Favorites: 3 Biotech Stocks With Strong Buy Ratings for April 2024 ↗

April 11, 2024

In a stock picker’s market, here are three biotech stocks analysts believe have a chance to outperform the market in 2024.

Via InvestorPlace

If You Invested $1000 In This Stock 5 Years Ago, You Would Have $2,000 Today ↗

March 19, 2024

Via Benzinga

Is It Too Late to Buy CRISPR Therapeutics Stock? ↗

March 16, 2024

The biotech has been making a lot of noise since late last year.

Via The Motley Fool

Better Buy: CRISPR Therapeutics Vs. Viking Therapeutics ↗

April 09, 2024

These rising drugmakers have serious arguments in their favor.

Via The Motley Fool

Bull Market and Beyond: 3 Stocks Just Waiting to Soar ↗

April 09, 2024

These stocks, a bargain today, are players to hold on to for the long term.

Via The Motley Fool

Better Growth Biotech Buy: Iovance Biotherapeutics vs CRISPR Therapeutics ↗

April 05, 2024

These companies are in the early days of their growth stories.

Via The Motley Fool

3 Unstoppable Stocks to Buy Hand Over Fist in April ↗

March 30, 2024

These stocks have exceptionally bright prospects.

Via The Motley Fool

Crispr Stock, A Cathie Wood Holding, Dives For The Fifth Straight Week — Here's Why ↗

March 28, 2024

The company is working to launch its Vertex-partnered gene-editing drug for sickle cell disease and beta thalassemia.

Via Investor's Business Daily

3 Biotech Stocks That Could Be Multibaggers in the Making: March Edition ↗

March 28, 2024

Discover these three biotech stocks set for major gains with groundbreaking health solutions. Invest in the future of medicine.

Via InvestorPlace

3 No-Brainer Healthcare Stocks to Buy Right Now for Less Than $1,000 ↗

March 27, 2024

Each of these three companies are entering a new era of growth.

Via The Motley Fool

Buying These Dirt-Cheap Stocks Could Be a Brilliant Move ↗

March 23, 2024

The price could be right for these three biopharma stocks.

Via The Motley Fool

3 Stocks That Could Be the Next Big Thing in Gene Editing ↗

March 21, 2024

Gene editing could revolutionize how millions of patients are treated. That could create big opportunities for gene-editing stocks.

Via InvestorPlace

Geron Stock Doubles After Imetelstat Receives FDA Panel Approval

March 20, 2024

Geron stock is up more than 92% after the company's flagship blood cancer therapy received approval from an FDA advisory panel

Via MarketBeat

The 3 Most Undervalued Cathie Wood Stocks to Buy in March 2024 ↗

March 15, 2024

These undervalued Cathie Wood stocks capture her favorite trends and remain undervalued even as the wider tech sector surge.

Via InvestorPlace

7 Biotech Stocks to Buy as Sector Rotation Ramps Up ↗

March 13, 2024

With digital innovation possibly getting overextended, now’s the time to consider biotech stocks for an incoming rotation.

Via InvestorPlace

Cathie Wood's Ark Invest Keeps Dumping Coinbase Shares Amid Bitcoin, Crypto Buzz ↗

March 12, 2024

On Tuesday, Cathie Wood-led Ark Invest made a significant move by offloading a substantial number of shares in Coinbase Global Inc (NASDAQ:COIN), despite Bitcoin (CRYPTO: BTC) reaching new

Via Benzinga

It's A Bull Market But Harder To Pick Small Cap Biotech Winners Because Of Volatility ↗

March 11, 2024

Biotech is in a bull market aș measured by 2023 trends with a double testing of lows on 11/23.

Via Talk Markets

The Top 3 Biotech Stocks to Buy in March 2024 ↗

March 06, 2024

Although the biotech sector puts the benefits and risks in plain sight, three top biotech stocks to buy shine for investors.

Via InvestorPlace

Beam Therapeutics Bolts Higher on Gene Therapy Licensing Payments

March 06, 2024

Beam Therapeutics stock is rising as the company begins to receive significant money from the multiple licensing deals it has in place

Via MarketBeat

Here's Why CRISPR Therapeutics Stock Climbed 34% in February ↗

March 05, 2024

The biotech company keeps moving closer to bringing its promising first gene therapy to market.

Via The Motley Fool

ChatGPT Stock Predictions: 3 Biotech Companies the AI Bot Thinks Have 10X Potential ↗

March 04, 2024

Here are three ChatGPT stock predictions for the most unpredictable of biotech stocks that might just have 10x potential.

Via InvestorPlace

Topics Artificial Intelligence

MarketBeat Week in Review – 2/26 - 3/1

March 02, 2024

As the calendar turns to March, investors continue to climb the wall of worry, but with the S&P 500 at 5,000, the MarketBeat team helps show you where to invest

Via MarketBeat

Topics Economy Stocks

CRISPR Therapeutics Stock Has 32% Upside, According to 1 Wall Street Analyst ↗

February 29, 2024

This company's fortunes are likely to improve, and soon.

Via The Motley Fool

A Bull Market Is Here: 2 Magnificent Stocks Down 80% to Buy Right Now ↗

February 29, 2024

The futures for these two beaten-down stocks could be brighter than their recent pasts.

Via The Motley Fool

Beam Rockets 27%, Hitting A Year High, On Its Efforts To Take On Crispr's New Gene-Editing Drug ↗

February 27, 2024

Both companies are working on treatments for genetic disorders.

Via Investor's Business Daily

3 Biotech Stocks Bound to Blast Off By 2029 ↗

February 27, 2024

Biotech stocks are risky, but rewarding. These three biotechs specifically could see exponential gains in the coming years.

Via InvestorPlace

< Previous 1 2

...

5 6 7 8 9 10 11 12 13

...

34 35 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.